Immune checkpoints such as PD-1 and PD-L1 were significantly highly expressed in C1 subtypes, while T-cell-inflamed GEP score and response to IFN-γ response were significantly elevated in C1 subtype, suggesting that ICB-based cancer immunotherapy regimens may be effective in LGG patients. Here, PDCD1 is linked to cancer.